Press releases & Media
Press releases
-
Groves Medical Group starts offering Stockholm3 in the UK
February 1, 2023
-
Clinical study validates that Stockholm3 provides significantly higher clinical benefit than European prostate cancer risk calculator
January 12, 2023
-
A3P Biomedical appoints Andreas Hoel as new VP of Marketing & Sales
November 1, 2022
A3P in media
-
Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
May 6, 2022
-
Finally time for public screening of prostate cancer? (In Swedish)
November 22, 2021
-
Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
October 6, 2021